139 related articles for article (PubMed ID: 35725386)
1. HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection.
Tarragó D; González I; González-Escribano MF
BMC Genomics; 2022 Jun; 23(1):455. PubMed ID: 35725386
[TBL] [Abstract][Full Text] [Related]
2. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
3. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
[TBL] [Abstract][Full Text] [Related]
4. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
Front Immunol; 2022; 13():1008220. PubMed ID: 36341392
[TBL] [Abstract][Full Text] [Related]
5. The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
Sullivan LC; Westall GP; Widjaja JM; Mifsud NA; Nguyen TH; Meehan AC; Kotsimbos TC; Brooks AG
PLoS One; 2015; 10(8):e0135972. PubMed ID: 26302084
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
[TBL] [Abstract][Full Text] [Related]
7. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
8. Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
Vietzen H; Hartenberger S; Jaksch P; Puchhammer-Stöckl E
J Heart Lung Transplant; 2021 Sep; 40(9):900-904. PubMed ID: 34183227
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.
Prod'homme V; Tomasec P; Cunningham C; Lemberg MK; Stanton RJ; McSharry BP; Wang EC; Cuff S; Martoglio B; Davison AJ; Braud VM; Wilkinson GW
J Immunol; 2012 Mar; 188(6):2794-804. PubMed ID: 22345649
[TBL] [Abstract][Full Text] [Related]
10. Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?
Waters S; Allcock RJN; Lee S; Downing J; Ariyanto I; Leary S; Munyard K; Irish A; Price P
Hum Immunol; 2023 Feb; 84(2):75-79. PubMed ID: 36456304
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell receptors regulate responses of HLA-E-restricted T cells.
Sullivan LC; Nguyen THO; Harpur CM; Stankovic S; Kanagarajah AR; Koutsakos M; Saunders PM; Cai Z; Gray JA; Widjaja JML; Lin J; Pietra G; Mingari MC; Moretta L; Samir J; Luciani F; Westall GP; Malmberg KJ; Kedzierska K; Brooks AG
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33893172
[TBL] [Abstract][Full Text] [Related]
12. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
Ulbrecht M; Martinozzi S; Grzeschik M; Hengel H; Ellwart JW; Pla M; Weiss EH
J Immunol; 2000 May; 164(10):5019-22. PubMed ID: 10799855
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
[TBL] [Abstract][Full Text] [Related]
15. Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells.
Rousselière A; Charreau B
Cells; 2023 Mar; 12(6):. PubMed ID: 36980230
[TBL] [Abstract][Full Text] [Related]
16. Maternal and child human leukocyte antigens in congenital cytomegalovirus infection.
Rovito R; Claas FHJ; Haasnoot GW; Roelen DL; Kroes ACM; Vossen ACTM
J Reprod Immunol; 2018 Apr; 126():39-45. PubMed ID: 29477013
[TBL] [Abstract][Full Text] [Related]
17. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC
Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus-Specific T Cell Epitope Recognition in Congenital Cytomegalovirus Mother-Infant Pairs.
Materne EC; Lilleri D; Garofoli F; Lombardi G; Furione M; Zavattoni M; Gibson L
Front Immunol; 2020; 11():568217. PubMed ID: 33329532
[No Abstract] [Full Text] [Related]
19. HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.
Allard M; Tonnerre P; Nedellec S; Oger R; Morice A; Guilloux Y; Houssaint E; Charreau B; Gervois N
PLoS One; 2012; 7(11):e50951. PubMed ID: 23226431
[TBL] [Abstract][Full Text] [Related]
20. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.
Pietra G; Romagnani C; Mazzarino P; Falco M; Millo E; Moretta A; Moretta L; Mingari MC
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10896-901. PubMed ID: 12960383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
